Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Fennec Pharmaceuticals (FENC) over the last 5 years, with Q3 2025 value amounting to $419000.0.

  • Fennec Pharmaceuticals' Treasury Shares rose 1416.89% to $419000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $419000.0, marking a year-over-year increase of 1416.89%. This contributed to the annual value of $324000.0 for FY2024, which is 4862.39% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Treasury Shares of $419000.0 as of Q3 2025, which was up 1416.89% from $485000.0 recorded in Q2 2025.
  • Fennec Pharmaceuticals' Treasury Shares' 5-year high stood at $589000.0 during Q1 2025, with a 5-year trough of $35000.0 in Q4 2022.
  • Moreover, its 5-year median value for Treasury Shares was $260000.0 (2023), whereas its average is $264529.4.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 52285.71% in 2023, then crashed by 2818.79% in 2024.
  • Over the past 5 years, Fennec Pharmaceuticals' Treasury Shares (Quarter) stood at $55000.0 in 2021, then plummeted by 36.36% to $35000.0 in 2022, then surged by 522.86% to $218000.0 in 2023, then skyrocketed by 48.62% to $324000.0 in 2024, then increased by 29.32% to $419000.0 in 2025.
  • Its Treasury Shares was $419000.0 in Q3 2025, compared to $485000.0 in Q2 2025 and $589000.0 in Q1 2025.